Crossmark

Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells

Crossref DOI link: https://doi.org/10.1007/s13402-018-0387-3

Published Online: 2018-07-25

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pelz, Carsten

Häckel, Sonja

Semini, Geo

Schrötter, Sandra

Bintig, Willem

Stricker, Sebastian

Mrawietz, Gudrun

Klein, Andreas

Lucka, Lothar

Shmanai, Vadim

Eickholt, Britta

Hildmann, Annette

Danker, Kerstin https://orcid.org/0000-0002-7214-4682
Funding

Funding for this research was provided by:

Berliner Krebsgesellschaft
License Information

Text and Data Mining valid from 2018-07-25
More Information

Article History

Accepted: 7 June 2018

First Online: 25 July 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interests.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study informed consent is not required